IMC Chicago’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10.4M Buy
58,300
+29,500
+102% +$4.82M ﹤0.01% 1611
2026
Q2
$4.32M Buy
28,800
+1,800
+7% +$196K ﹤0.01% 2250
2026
Q1
$2.49M Sell
27,000
-20,600
-43% -$2.07M ﹤0.01% 2365
2025
Q4
$4.86M Buy
47,600
+17,600
+59% +$1.57M ﹤0.01% 1754
2025
Q3
$1.87M Buy
30,000
+14,300
+91% +$778K ﹤0.01% 2276
2025
Q2
$817K Buy
+15,700
New +$701K ﹤0.01% 2598

Other funds holding GH

IMC Chicago's GH Position: Q3 2026 in Review

IMC Chicago sold out of Guardant Health (GH) in Q3 2026, closing a stake of 13,342 shares — an estimated $2.18M sold.

IMC Chicago first reported a position in GH in Q4 2025 and held it in 3 quarters. The position peaked at $2M in Q2 2026. 511 funds tracked by Wall St. Rank hold GH as of Q3 2026.

  • IMC Chicago reported no remaining Guardant Health position as of Q3 2026 after selling out during the quarter.
  • IMC Chicago sold 13,342 Guardant Health shares in Q3 2026, an estimated $2.18M.
  • IMC Chicago first reported a position in Guardant Health in Q4 2025 and held it in 3 quarters.
  • IMC Chicago's Guardant Health position peaked at $2M in Q2 2026.
  • 511 funds tracked by Wall St. Rank held Guardant Health as of Q3 2026.

Based on IMC Chicago's 13F filing for Q3 2026, filed 5 Nov 2026.